<DOC>
	<DOC>NCT00393965</DOC>
	<brief_summary>Phase 1, Multiple dose Study of MPC-6827 in Subjects with Refractory Brain Metastases.</brief_summary>
	<brief_title>Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Refractory Brain Metastases At least 1 measurable intracranial lesion as defined by RECIST ECOG less than or equal to 1 Adequate hematology/organ function No baseline peripheral or central neuropathy above grade 1 Hypersensitivity to Cremophor EL Pregnant or Lactating Spinal Cord Compression Preexisting dementia/cognitive disfunction Require Neupogen or Neulasta to Maintain Neutrophil Count Have Primary Brain Cancer Have History of Ischemic Heart Disease Have Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Metastases</keyword>
	<keyword>Refractory</keyword>
	<keyword>Brain</keyword>
</DOC>